NUZEFATIDE PEVEDOTIN
UNII CIT3DOS0DW
Substance Identification & Data
This profile provides standardized clinical and technical data for Nuzefatide Pevedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) CIT3DOS0DW.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2648849-70-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
CIT3DOS0DW
2648849-70-9
N/A
Detailed Substance Profile
Preferred Name
NUZEFATIDE PEVEDOTIN
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C201H315N53O52S3 International Chemical Identifier digital signature for unique molecular identification.
SMILES String
YZUGAHYDHBVJAU-LOXUOWRQSA-N Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
13426
Sequential identifier assigned via the WHO International Nonproprietary Name program.
USAN ID
OP-124
Identifier assigned by the United States Adopted Names Council.
Substance Type
Nuzefatide Pevedotin
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C(c1c2c([nH]c1)cccc2)[C@@H]3NC([C@H](NC(=O)[C@]4(N(C(=O)[C@@H](NC([C@@H](NC([C@@H]5CSCCC(=O)N6CN(CN(C6)C(=O)CCSC[C@@H](C(N7[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N8[C@H](C(N[C@H](C(N5)=O)CC(C)C)=O)CCC8)=O)CC(N)=O)=O)C(C)C)=O)CC(C)C)=O)C[C@H](C7)O)=O)NC(=O)[C@H](CC(O)=O)NC([C@H](CCCCNC(N)=N)NC([C@@H](NC(CN(C(CN(C(CN(C(CN(C(CN(C(CN(C(CN(C(CN(C(CN(C(CN(C(CCNC(CCCC(N[C@@H](C(C)C)C(N[C@@H](CCCNC(=O)N)C(=O)Nc9ccc(cc9)COC(=O)N([C@H](C(N[C@H](C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N%10CCC[C@H]%10[C@H](OC)[C@@H](C)C(N[C@H](C)[C@@H](O)c%11ccccc%11)=O)=O)C)=O)C(C)C)=O)C(C)C)C)=O)=O)=O)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)C)=O)=O)C(CCSC[C@@H](C(N)=O)NC(=O)[C@H](CCCCNC(=N)N)NC3=O)=O)=O)CC(C)C)=O)Cc%12[nH]cnc%12)CCC4)[H])CC(=O)O)=O
Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Nuzefatide Pevedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.
FDA Official Name
Nuzefatide Pevedotin
Common Names & Synonyms
NUZEFATIDE PEVEDOTIN [USAN]
S<sup>3.15</sup>,S<sup>3.22</sup>,S<sup>3.29</sup>-[(1,3,5-triazinane-1,3,5-triyl)tris(3-oxopropane-3,1-diyl)]{N-[5-oxo-5-({L-valyl-N<sup>5</sup>-carbamoyl-L-ornithyl[(4-aminophenyl)methoxy]carbonyl-N-methyl-L-valyl-Lvalyl-(3R,4S,5S)-3-methoxy-5-methyl-4-(methylamino)heptanoyl-(2R,3R)-N-[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]-3-methoxy-2-methyl-3-[(2S)-pyrrolidin-2-yl]propanamide}-N2.1-yl)pentanoyl]-β-alanyldecakis(N-methylglycyl)-L-alanyl-N6-carbamimidoyl-L-lysyl-L-α-aspartyl-L-cysteinyl-(4R)-4-hydroxy-L-prolyl-L-leucyl-L-valyl-L-asparaginyl-L-prolyl-L-leucyl-L-cysteinyl-L-leucyl-L-histidyl-L-prolyl-D-α-aspartyl-L-tryptophyl-N6-carbamimidoyl-L-lysyl-Lcysteinamide}
nuzefatide pevedotin [INN]
Systematic Nomenclature
(3S)-4-[[(9R,13R,15S,18S,21S,24S,30S,33S,36R,39S,42S,48S,51R,54S,57S,60R)-24-(2-amino-2-oxoethyl)-57-(4-carbamimidamidobutyl)-60-carbamoyl-51-(carboxymethyl)-13-hydroxy-42-(1H-imidazol-5-ylmethyl)-54-(1H-indol-3-ylmethyl)-18,33,39-tris(2-methylpropyl)-4,10,16,19,22,25,31,34,37,40,43,49,52,55,58,65,68-heptadecaoxo-21-propan-2-yl-7,62,71-trithia-1,3,11,17,20,23,26,32,35,38,41,44,50,53,56,59,66-heptadecazahexacyclo[34.31.5.13,66.011,15.026,30.044,48]triheptacontan-9-yl]amino]-3-[[(2S)-6-carbamimidamido-2-[[(2S)-2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[3-[[5-[[(2S)-1-[[(2S)-5-(carbamoylamino)-1-[4-[[[(2S)-1-[[(2S)-1-[[(3R,4S,5S)-1-[(2S)-2-[(1R,2R)-3-[[(1S,2R)-1-hydroxy-1-phenylpropan-2-yl]amino]-1-methoxy-2-methyl-3-oxopropyl]pyrrolidin-1-yl]-3-methoxy-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]-methylcarbamoyl]oxymethyl]anilino]-1-oxopentan-2-yl]amino]-3-methyl-1-oxobutan-2-yl]amino]-5-oxopentanoyl]amino]propanoyl-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]-methylamino]acetyl]amino]propanoyl]amino]hexanoyl]amino]-4-oxobutanoic acid
L-Cysteinamide, N-(4-carboxy-1-oxobutyl)-β-alanyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-N-methylglycyl-L-alanyl-N6-(aminoiminomethyl)-L-lysyl-L-α-aspartyl-S-[3-oxo-3-[tetrahydro-3,5-bis(3-mercapto-1-oxopropyl)-1,3,5-triazin-1(2H)-yl]propyl]-L-cysteinyl-(4R)-4-hydroxy-L-prolyl-L-leucyl-L-valyl-L-asparaginyl-L-prolyl-L-leucyl-L-cysteinyl-L-leucyl-L-histidyl-L-prolyl-D-α-aspartyl-L-tryptophyl-N6-(aminoiminomethyl)-L-lysyl-, cyclic (15→22),(15→29)-bis(thioether), (1→1′)-amide with N-methyl-N-[[[4-[[L-valyl-N5-(aminocarbonyl)-L-ornithyl]amino]phenyl]methoxy]carbonyl]-L-valyl-N-[(1S,2R)-4-[(2S)-2-[(1R,2R)-3-[[(1R,2S)-2-hydroxy-1-methyl-2-phenylethyl]amino]-1-methoxy-2-methyl-3-oxopropyl]-1-pyrrolidinyl]-2-methoxy-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-L-valinamide
Technical Codes
BT-5528
BT5528
